Ixico Share News (IXI)
IXI Share
IXI Share
IXI Share
IXI Share
IXI
IXI Share
IXI Level 2
IXI Live
IXI Broker
IXI Directors
IXI Financial
IXI
IXI Short
IXI
Last checked at -
Tue, 04th Dec 2018 08:21
(Alliance News) - Ixico PLC on Monday said it has signed a supply agreement with Life Molecular Imaging GmbH, in a deal the company says will complement its "well-established PET imaging services and image data analytics".
Read more(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical trials.
Read moreIxico PLC - neuroscience focused advanced analytics company - Collaborates with IMEKA Solutions Inc, to provide access to Imeka's suite of services for white matter imaging deployed in Alzheimer's disease and multiple sclerosis clinical trials, amongst other CNS indications. Says Imeka's diffusion MRI algorithms will be made available to Ixico's global biopharma clients.
Read more(Alliance News) - Ixico PLC shares dropped sharply on Wednesday, after it said delays to projects will result in lower annual revenue.
Read more(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked by extended contracting cycles and delays in securing certain new contracts.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read more(Alliance News) - European equities kicked off Wednesday largely on the front foot, picking up the baton after US stocks resumed an "inexorable march" on Tuesday, after shaking off a hot US inflation reading.
Read more| Friday 19 January | |
| Cardiff Property PLC | AGM |
| Character Group PLC | AGM |
| Focusrite PLC | AGM |
| Substrate Artificial Inteligence SA | GM re investment agreement and issue of equity |
| Monday 22 January | |
| Highcroft Investments PLC | GM re de-listing from LSE and relisting on TISE |
| Smart Metering Systems PLC | GM & court meeting re takeover by funds advised by KKR |
| Tuesday 23 January | |
| C4X Discovery Holdings PLC | AGM |
| Marston's PLC | AGM |
| Mitchells & Butlers PLC | AGM |
| Wednesday 24 January | |
| Henderson Far East Income Ltd | AGM |
| Lowland Investment Co PLC | AGM |
| Tracsis PLC | AGM |
| Thursday 25 January | |
| Alteration Earth PLC | AGM |
| Britvic PLC | AGM |
| Greencore Group PLC | AGM |
| Henderson European Focus Trust PLC | AGM |
| Ixico PLC | AGM |
| Comments and questions to newsroom@alliancenews.com | |
| A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
| Copyright 2024 Alliance News Ltd. All Rights Reserved. | |
(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.
Read more(Alliance News) - Ixico PLC on Friday said that Chief Executive Officer Giulio Cerroni will retire from his role by the end of 2024.
Read more(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it faced a minor revenue shortfall.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of their phase 2b trial for Huntington's disease (HD).
Read more
Last checked at